September 21, 2020 by Chain Drug Review
Amber, Hy-Vee, specialty pharmacy
Leading Headlines, Pharmacy, Retail News
OMAHA — Amber Specialty Pharmacy, a subsidiary of Hy-Vee Inc., has been named 2020 Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy (NASP). The prestigious award was presented by NASP chairman Carmine DeNardo and Sheila Arquette, the organization’s president and CEO, during the eighth annual NASP Annual Meeting & Expo held
August 4, 2020 by Chain Drug Review
Brian Seiz, specialty pharmacy, Surescripts, Tim Gallagher, Tom Skelton
Leading Headlines, Pharmacy
ARLINGTON, Va.— Surescripts is further streamlining the specialty medication process with two new network services. Specialty pharmacies can now gather clinical information and conduct prior authorizations within their workflow, enabling patients to get on therapy faster and giving specialty pharmacists more time to serve as trusted partners and resources for patients with serious and complex
November 14, 2018 by Chain Drug Review
Coram, CVS, home infusion, specialty pharmacy
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — Coram CVS Specialty Home Infusion Services has earned The Joint Commission’s Gold Seal of Approval for Home Care Accreditation. By earning the accreditation for the third time, Coram has demonstrated continuous compliance with its performance standards. The gold seal is a symbol of quality that reflects Coram’s commitment to providing safe and
April 18, 2018 by Chain Drug Review
earnings, Fred's, Mike Bloom, specialty pharmacy
Featured Articles, Leading Headlines, Pharmacy, Retail News
MEMPHIS — Fred’s Inc. has announced plans to sell its specialty pharmacy business. The disclosure led the company to delay publication of its fourth quarter and 2017 full-year results. An earnings call that was slated for today is now expected to be held May 4. A filing yesterday with the Securities and Exchange Commission says
February 22, 2018 by Chain Drug Review
biosimilars, Diplomat Pharmacy, Jeff Park, Joel Saban, specialty drug pipeline, specialty pharmacy
Leading Headlines, Pharmacy, Retail News
FLINT, Mich. — Biosimilars, generic drugs and affordable branded drugs are top-of-mind at Diplomat Pharmacy Inc. this year as the specialty pharmacy looks to help health plans and patients rein in costs. According to Diplomat president Joel Saban, the surging market for expensive specialty drugs has put pressure on stakeholders across the health care sector.
January 29, 2018 by Chain Drug Review
AllianceRx Walgreens Prime, Matt Farber, Rick Miller, specialty pharmacy, Walgreens, Walgreens Connected Care Oncology
Leading Headlines, Pharmacy, Retail News, Technology
DEERFIELD, Ill — Walgreens has received a U.S. patent for new proprietary technology in its Connected Care Oncology specialty pharmacy program. An evidence-based, patient-centered solution, Walgreens Connected Care Oncology focuses on driving medication adherence and improving patient outcomes, and the technology helps guide interactions with patients, helping them to stay on their treatment regimens and manage any
January 5, 2018 by Chain Drug Review
Ben Wolin, Dale Hagerman, Diplomat Pharmacy, Jeff Park, Phil Hagerman, specialty pharmacy
Business, Leading Headlines, Pharmacy, Retail News
FLINT, Mich. — Phil Hagerman, co-founder, chairman and chief executive officer of Diplomat Pharmacy Inc., the nation’s largest independent specialty pharmacy, plans to retire. Diplomat said Friday that board member Jeff Park has been named interim CEO, and independent lead director Ben Wolin has been appointed chairman. Both moves are effective immediately. Diplomat’s board has launched
November 16, 2017 by Chain Drug Review
Albert Thigpen, Diplomat Pharmacy, Joel Saban, LDI Integrated Pharmacy Services, Len Dino, National Pharmacy Services, pharmacy benefit manager, Phil Hagerman, specialty pharmacy
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News
FLINT, Mich. — Diplomat Pharmacy Inc. plans to acquire St. Louis-based pharmacy benefit manager LDI Integrated Pharmacy Services for in a $595 million cash and stock deal. The move marks the second PBM acquisition this month by Diplomat, the nation’s largest independent specialty pharmacy. On Nov. 6, the company announced the purchase of National Pharmacy
November 6, 2017 by Chain Drug Review
drug pricing, Hercules Pharmaceuticals, NASP, National Association of Specialty Pharmacy, Onco360, Paul Jardina, Sheila Arquette, specialty pharmacy, Timothy Ward, Tom Suozzi
2017, Issue 11-06-2017, Issues, News
GREAT NECK, N.Y. — Rep. Tom Suozzi (D., N.Y.) got an education on drug cost dynamics during a tour of oncology pharmacy Onco360 here with members of the National Association of Specialty Pharmacy (NASP). Vice chairman of the Problem Solvers Caucus in the House of Representatives, Suozzi said he made the visit to learn more
October 19, 2017 by Chain Drug Review
DIR fees, Hercules Pharmaceuticals, NASP, National Association of Specialty Pharmacy, Onco360, Paul Jardina, Sheila Arquette, slideshow, specialty drugs, specialty pharmacy, Timothy Ward, Tom Suozzi
Featured Articles, Leading Headlines, Pharmacy, Retail News, Slideshows
GREAT NECK, N.Y. — Rep. Tom Suozzi (D., N.Y.) gauged cost dynamics of the specialty pharmacy market in a tour of oncology pharmacy Onco360 here with members of the National Association of Specialty Pharmacy (NASP). Seeking insight on what’s driving skyrocketing drug costs and the impact on patients, Suozzi met with Sheila Arquette, executive director
October 3, 2017 by Chain Drug Review
AllianceRx Walgreens Prime, Joel Wright, Prime Therapeutics, specialty pharmacy, Walgreens
Featured Articles, Leading Headlines, Pharmacy, Retail News
ORLANDO, Fla. — Walgreens and Prime Therapeutics LLC have inaugurated AllianceRx Walgreens Prime, the brand for the joint central specialty pharmacy and mail services company they formed earlier this year. The companies said the AllianceRx Walgreens Prime launch included the unveiling of new signage at its headquarters in Orlando, Fla., and at other company-owned facilities
July 3, 2017 by Rodey Wing, Ella Berlyand, Katy Rauen and Chain Drug Review
A.T. Kearney, accredited URAC pharmacy, Ella Berlyand, Katy Rauen, limited-distribution drugs, Rodey Wing, specialty pharmacy, specialty pharmacy industry
2017, Issue 07-03-2017, Issues, Opinion
In recent years, the specialty pharmacy industry has been defined by rapid growth with considerable entry from new participants. Factors driving growth include an increase of therapies introduced into the pharmacy benefit class rather than through the medical benefit, a growing number of patients receiving treatment for a wider range of conditions, price inflation caused
May 9, 2017 by Chain Drug Review
Diplomat Pharmacy, Envoy Health Management, EnvoyHealth, Jennifer Cretu, Phil Hagerman, Ron Abel, specialty pharmacy, WRB Communications
Business, Pharmacy, Retail News
FLINT, Mich. — Diplomat Pharmacy Inc. has acquired WRB Communications Inc., a Chantilly, Va.-based operator of health care contact centers, in a $29 million deal. Under the agreement, announced late Monday, Diplomat is paying WRB $24.5 million in cash and $4.5 million in common stock. Plans call for WRB to join Diplomat’s Envoy Health Management
April 13, 2017 by Chain Drug Review
Atheer Kaddis, Corizon Health, Diplomat Pharmacy, Mark Moyers, PharmaCorr, specialty drugs, specialty pharmacy
Pharmacy, Retail News
FLINT, Mich. — Diplomat Pharmacy Inc. has been selected to provide pharmacy services and dispense limited-distribution specialty drugs for Corizon Health’s clients and support its in-house mail-order pharmacy PharmaCorr. Diplomat, the nation’s largest independent specialty pharmacy, said the three-year agreement supports specialty pharmacy services for 321,000 patients across 25 states. Corizon Health, based in Brentwood,